CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulation

Por Roca, Hernan, Varsos, Zachary, Pienta, Kenneth J.
Publicado em 2008

CCL2 Is a Negative Regulator of AMP-Activated Protein Kinase to Sustain mTOR Complex-1 Activation, Survivin Expression, and Cell Survival in Human Prostate Cancer PC3 Cells

Por Roca, Hernan, Varsos, Zachary S, Pienta, Kenneth J
Publicado em 2009

CCL2 and Interleukin-6 Promote Survival of Human CD11b(+) Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization

Por Roca, Hernan, Varsos, Zachary S., Sud, Sudha, Craig, Matthew J., Ying, Chi, Pienta, Kenneth J.
Publicado em 2009

The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment

Por Mizutani, Kosuke, Sud, Sudha, McGregor, Natalie A, Martinovski, Gari, Rice, Brandon T, Craig, Matthew J, Varsos, Zachary S, Roca, Hernan, Pienta, Kenneth J
Publicado em 2009

IL-4 induces proliferation in prostate cancer PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway and survivin upregulation

Por Roca, Hernan, Craig, Matthew J., Ying, Chi, Varsos, Zachary S., Czarnieski, Paul, Alva, Ajjai S., Hernandez, James, Fuller, David, Daignault, Stephanie, Healy, Patrick N., Pienta, Kenneth J.
Publicado em 2012